🇺🇸 FDA
Patent

US 8673964

Use of drug combinations for treating insulin resistance

granted A61KA61K31/155A61K31/198

Quick answer

US patent 8673964 (Use of drug combinations for treating insulin resistance) held by DiaMedica Inc. expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DiaMedica Inc.
Grant date
Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/155, A61K31/198, A61K31/27, A61K31/4439